Navigation Links
Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse

itable moods while taking Strattera, you should report them to your child's doctor right away.

For male patients, if you are taking Strattera and experience priapism, a painful or prolonged erection lasting more than four hours, call your doctor right away. As with all ADHD medications, growth should be monitored during treatment, although height and weight data measured for up to three years indicates minimal, if any, long-term effects.

Most people in clinical studies who experienced side effects were not bothered enough to stop using Strattera. The most common side effects in children and adolescents in medical studies were upset stomach, decreased appetite, nausea and vomiting, dizziness, tiredness and mood swings. In adults, the most common side effects were constipation, dry mouth, nausea, decreased appetite, dizziness, problems sleeping, sexual side effects, problems urinating and menstrual cramps.

For Medication Guide, visit www.Strattera.com.

For full Prescribing Information, including Boxed Warning information, visit http://www.Strattera.com/.

About Eli Lilly and Company

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers -- through medicines and information -- for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com.

P-LLY

This press release contains forward-looking statements about Strattera for the treatment of ADHD and reflects Lilly's current beliefs. However, as with any pharmaceutical product, ther
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
(Date:10/1/2014)... 2014  CVS Health is thanking its 26,000 pharmacists ... changing the way health care is delivered to increase ... retail pharmacies, mail service pharmacies and specialty pharmacies nationwide.  ... name to CVS Health to reflect our broader health ... needed to shape the future of health," said ...
(Date:9/30/2014)... - Protecting the health and safety of Canadians is our government,s ... powers and tools at its disposal to help ensure that the ... To that end, Health Canada ... Canada of all drug products from three plants ... , Apotex Pharmachem India Pvt Ltd , Apotex Research ...
(Date:9/30/2014)... BEDFORD, Mass. , Sept. 30, 2014  Hologic, ... Stephen MacMillan , Hologic,s President and Chief Executive ... Bell Ceremony on October 1, the first day of ... will discuss the Company,s campaign focused on the important ... system approved by the FDA as clinically superior to ...
Breaking Medicine Technology:CVS Health Thanking its Pharmacists during American Pharmacists Month for Helping People on Their Path to Better Health 2CVS Health Thanking its Pharmacists during American Pharmacists Month for Helping People on Their Path to Better Health 3Statement by the Honourable Rona Ambrose on the import ban of drug products from three plants in India 2Hologic to Kick Off National Breast Cancer Awareness Month at the October 1 NASDAQ Stock Market Opening Bell Ceremony 2Hologic to Kick Off National Breast Cancer Awareness Month at the October 1 NASDAQ Stock Market Opening Bell Ceremony 3
... , Knights of Columbus partners with Medishare to provide physical therapy and prosthetic limbs ... WASHINGTON , Aug. 4 ... aid of every Haitian child who lost a limb in the January earthquake that ... Many thousands more were seriously injured, including hundreds of children who lost arms and ...
... OvaGene Oncology Inc., a biotechnology ... DNA-based diagnostics for gynecologic cancer, is pleased to announce ... the Industry Collaboration Team (ICT) program.  By becoming a ... to building a strong partnership with the GOG research ...
Cached Medicine Technology:New Program Makes Prosthetics Available to All Haitian Children Who Lost Limbs in Earthquake 2OvaGene Oncology Joins The Gynecologic Oncology Group (GOG) Industry Collaboration Team to Advance Gynecologic Cancer Research 2OvaGene Oncology Joins The Gynecologic Oncology Group (GOG) Industry Collaboration Team to Advance Gynecologic Cancer Research 3
(Date:10/1/2014)... Familylifeinsurancequotes.org has released a new blog ... citizens. , Senior citizens can qualify for affordable ... to seniors who are over 50 years old. Some ... a medical examination. , Term life insurance with a ... can qualify. Having life insurance during retirement is important ...
(Date:10/1/2014)... 2014 Bedros Keuilian is not only ... fitness boot camps, he’s also considered the leading expert ... sold out business summits, a line of high-demand fitness ... a recent Spike TV reality show to his name. ... the time for personal trainers and fitness business owners ...
(Date:10/1/2014)... October 01, 2014 Phoseon Technology, the ... continues to expand the business worldwide. This rapid growth ... additional capacity for manufacturing efforts. The company has experienced ... five years and expects this growth to continue in ... technology gains worldwide adoption. , “We are very ...
(Date:10/1/2014)... Join the more than 80 golfers who already ... ever charity golf tournament to benefit Project HEAL, a not-for-profit ... cannot afford treatment. The tournament will be held Monday, Oct. ... , The day-long event starts with 10:30 a.m. check-in and ... will begin at 5 p.m. and will include an auction ...
(Date:10/1/2014)... Between 23 million and 50 million ... to figures from the National Institutes of Health (NIH) ... many of them have something else in common: They ... disease. Gluten Free Therapeutics, makers of CeliVites ... disease by publishing a series of blog posts aimed ...
Breaking Medicine News(10 mins):Health News:Affordable Term Life Insurance - Senior Citizens Can Qualify for Coverage! 2Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 2Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 3Health News:Phoseon Technology Continues to Drive Growth Worldwide 2Health News:Project HEAL Benefit Golf Tournament Gaining Momentum 2Health News:Project HEAL Benefit Golf Tournament Gaining Momentum 3Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 2Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 3
... Breaking news on sexual performance, diabetes, combating obesity, steroid ... a series of news briefings at ENDO 08, the ... Sunday, June 15 , Sexy Sex Findings ... men and women. Topics include erectile dysfunction, boosting womens ...
... a global,provider of products and services that improve the ... of directors has approved a 17,percent increase in the ... regular quarterly dividend is payable on July 15 to ... a 12-cents-per-share quarterly,dividend since July 15, 2007 and has ...
... May 5, 2008/Saranac Lake, N.Y.-- On May 12, 2008, ... stamp in their Distinguished Americans series. The stamp, the ... Trudeau (1848-1915). Stamp collecting is one of the most ... to 20 million American collectors participating in the activity. ...
... http://www.nhs.uk ), the new,digital ,front door, to the ... to,help people stay healthy during their travels abroad., ... Well Travel health guide,( http://www.nhs.uk/livewell/travelhealth/Pages/Travelhealthhome.aspx ),enables users to ... clinically approved guidance to help them stay healthy ...
... May 7 DaVita Inc. (NYSE:,DVA) announced ... an increase to,its current stock repurchase program. ... the repurchase of $250,000,000 of,the Company,s common ... expiration,date., (Logo: http://www.newscom.com/cgi-bin/prnh/20020729/DAVITALOGO ), ...
... 7 Genzyme Corp.,(Nasdaq: GENZ ) reported ... an,ongoing open-label Phase 2 clinical trial of its ... a meaningful impact,on key clinical manifestations of Gaucher ... to become an innovative treatment option for,Gaucher disease., ...
Cached Medicine News:Health News:ENDO 08 preliminary news conference and webcast schedule 2Health News:Cardinal Health Increases Quarterly Dividend by 17 Percent 2Health News:New United States Postal Service stamp honors an American scientist 2Health News:New United States Postal Service stamp honors an American scientist 3Health News:Preliminary Results from Phase 2 Genzyme Study Highlight Potential of Novel Oral Compound for Gaucher Disease 2Health News:Preliminary Results from Phase 2 Genzyme Study Highlight Potential of Novel Oral Compound for Gaucher Disease 3Health News:Preliminary Results from Phase 2 Genzyme Study Highlight Potential of Novel Oral Compound for Gaucher Disease 4Health News:Preliminary Results from Phase 2 Genzyme Study Highlight Potential of Novel Oral Compound for Gaucher Disease 5
... TRACH CARE Dual Lumen, allows ... the patient end of the ... Swivel Elbow and Direction Tip ... Offers multiple tracheostomy sizes, French ...
... TRACH CARE WET PAK is ... Double Swivel Elbow configurations. Catheters ... vials per catheter. Features lavage/irrigation ... French sizes and packaging configurations. ...
... BALLARD Adult TRACH CARE ... endotracheal intubated patients. Rounded ... provide smooth surface interface. ... locking thumb port. Offers ...
... Our soft, flexible whistle tip suction ... kit that includes: One pair of ... 120 ml bottle of sterile saline. ... use with cuffed gloves and catheter ...
Medicine Products: